NEW YORK, 8 July 2021 – UNICEF has signed an agreement with Janssen Pharmaceutica NV to provide up to 220 million doses of single-dose J&J vaccines for the 55 member states of the African Union by the end of 2022. Some 35 million doses are expected to be distributed by the end of the year. In November 2020, the African Union established AVAT to provide COUNTER-19 vaccines on the African continent, with the aim of vaccinating 60% of the population of each AU country. As part of this plan, the African Export Import Bank (Afreximbank) and AVAT have signed, on behalf of the AU, a cooperation agreement for the development of an Advance Supply Contract (APC) Framework to support Member States` access to COVID-19 vaccines. UNICEF will provide and provide COVID-19 vaccines on behalf of the AVAT initiative. The Africa Centres for Disease Control and Prevention (Africa CDC) and the World Bank are other partners. While several vaccines are expected to be part of the initiative`s portfolio, Janssen`s single-dose vaccine is the first to be included. While it`s important to secure long-term care and maintain the current configuration of a component crucial to the design of your medical device, the process may require a little more complexity. Typical components that can be subject to controls are those that are exclusively purchased or that are essential for the performance or safety of your medical device. A supplier quality agreement or delivery agreement may be required. The deal comes to a country where the African continent is facing the largest increase in COVID-19 cases to date and where vaccine supply challenges have left many countries whose populations are unvaccinated.